These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5296087)

  • 1. Treatment of haemophilia A and v. Willebrand's disease.
    Nilsson IM
    Bibl Haematol; 1965; 23():1307-12. PubMed ID: 5296087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of plasma and/or factor VIII concentrates administration on platelet functions in patients with haemophilia A and von Willebrand's disease (author's transl)].
    Gamba G; Grignani G; Nicolini E; Ascari E
    Haematologica; 1975 Jun; 60(2):168-83. PubMed ID: 808449
    [No Abstract]   [Full Text] [Related]  

  • 3. Correction of the platelet abnormality in von Willebrand's disease by cryoprecipitate.
    Weiss HJ; Rogers J
    Am J Med; 1972 Dec; 53(6):734-8. PubMed ID: 4539018
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
    Janković GM
    Thromb Res; 1979; 16(3-4):557-64. PubMed ID: 316208
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital bleeding disorders: hemophilia and von Willebrand's disease.
    Gill FM
    Med Clin North Am; 1984 May; 68(3):601-15. PubMed ID: 6431208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
    Janković GM; Janosević S
    Haematologia (Budap); 1978-1979; 12(1-4):183-8. PubMed ID: 317061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.
    Holmberg L; Borge L; Nilsson IM
    Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing mild hemophilia A from von Willebrand's syndrome.
    Sabo MG; Triplett DA; Peden JC
    Am J Med Technol; 1978 May; 44(5):455-63. PubMed ID: 307909
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of hepatitis A after treatment with pasteurised factor VIII concentrates in children with haemophilia A and von Willebrand disease.
    Kreuz W; Klarmann D; Auerswald G; Auberger K; Gürtler L; Rabenau H; Doerr WD
    Lancet; 1993 Feb; 341(8842):446. PubMed ID: 8094219
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical aspects of hemophilia and von Willebrand's disease.
    Ciavarella D; Counts RB
    Am J Med Technol; 1983 Dec; 49(12):850-4. PubMed ID: 6422754
    [No Abstract]   [Full Text] [Related]  

  • 13. NORMAL AND POST-EXERCISE PLASMA TRANSFUSION IN PATIENTS WITH HAEMOPHILIA A AND VON WILLEBRAND'S DISEASE.
    IKKALA E; MYLLYLAE G; NEVANLINNA HR
    Scand J Haematol; 1964; 1():300-7. PubMed ID: 14232714
    [No Abstract]   [Full Text] [Related]  

  • 14. Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P) in von Willebrand disease and haemophilia A: a viewpoint by Eric Berntorp.
    Berntorp E
    Drugs; 2007; 67(10):1520. PubMed ID: 17600396
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of transfusions of serum during Willebrand's disease].
    Goudemand M; Habay D; Parquet-Gernez A
    Nouv Rev Fr Hematol; 1965; 5(3):492-8. PubMed ID: 4220817
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
    Lian EC; Deykin D
    Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of haemophilia and von Willebrand's disease.
    Ekert H; Muntz RH
    Aust N Z J Med; 1974 Feb; 4(1):66-70. PubMed ID: 4602351
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.
    Wensley RT; Stevens RF; Burn AM; Delamore IW
    Br Med J; 1980 Nov; 281(6252):1388-9. PubMed ID: 6777018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Question of thrombocytopathy in von Willebrand's disease].
    Barbui T; Battista R; Cazzavillan M; Dini E
    Minerva Med; 1974 Mar; 65(20):1066-70. PubMed ID: 4545297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.